See how variable-substituent quinoline compounds target inflammatory diseases across organs while reducing inflammation and symptoms.
Electrolytic oxidation of tailored sugar building blocks improves glycan yield and stereoselectivity while suppressing glycosylation side reactions.
Peptides and nucleic acids struggle to cross mitochondrial membranes; non-peptidic CPMs mediate targeted delivery of therapeutic cargo.
Lipid, peptide, and carbohydrate linkages create biosurfactants that stabilize emulsions, produce foam, and lower surface tension.